📅 2026 Update: Changes in Ketamine Regulations and Telehealth Services

Since the original article was published, there have been significant updates in U.S. drug laws and telehealth services related to controlled substances like ketamine. These changes impact how patients can access treatment, especially for mental health and substance use disorders. The earlier article continues further down the page for additional context.

🩺 Telemedicine Flexibilities Extended

The U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have extended telemedicine flexibilities for prescribing controlled substances through December 31, 2026. This allows registered practitioners to prescribe Schedule II-V medications via telehealth without requiring an in-person visit first.

💊 Permanent Buprenorphine Prescribing Rule

On January 17, 2025, the DEA and HHS made telemedicine flexibilities for prescribing buprenorphine permanent. This rule ensures that patients with opioid use disorder can continue to access this crucial treatment through telehealth platforms, improving access to care.

⚖️ Strengthening Mental Health Parity

Final rules released on September 9, 2024, enhance the Mental Health Parity and Addiction Equity Act (MHPAEA). These rules, effective November 22, 2024, ensure that mental health and substance use disorder benefits are treated equally to medical and surgical benefits. This is significant for those seeking treatment for addiction or mental health issues.

⏱️ Processing Times for Telehealth

Processing times for telehealth prescriptions can vary by provider. Some platforms might offer same-day consultations, while others may take longer to schedule an appointment. Patients should check with their chosen provider for specific timelines.

📌 Key Points Summary

  • Telemedicine flexibilities for controlled substances are extended to December 31, 2026.
  • Buprenorphine prescribing via telehealth is now permanent.
  • Mental health parity rules strengthen access to treatment.
  • Processing times for telehealth prescriptions can vary widely.
  • Patients should verify eligibility and consult providers for specific costs.

💡 Tips for Navigating Ketamine Treatment Options

Review the specifics of your situation with your attorney to explore your legal options effectively.

🏥 Understand Telehealth Requirements

To receive telehealth prescriptions for controlled substances, patients must have a video consultation with a DEA-registered practitioner. This consultation is necessary to assess medical history and current conditions.

💸 Check Costs Ahead of Time

Costs for telehealth consultations and medications like buprenorphine can vary by provider. It is beneficial to inquire about pricing upfront to avoid unexpected expenses.

📅 Stay Aware of Expiration Dates

The current telemedicine flexibilities for prescribing controlled substances are in effect until December 31, 2026. Be mindful of this deadline when seeking treatment.

📝 Complete Necessary Forms

Patients interested in buprenorphine treatment should find a provider that offers this service and ensure they complete any required intake forms before the consultation.

📞 Utilize Free Resources

For additional support, patients can contact the Substance Abuse and Mental Health Services Administration (SAMHSA) for treatment referrals. They also provide a national helpline at 1-800-662-HELP (4357).

🏆 Top Telehealth Services for Ketamine and Mental Health (Ranked by User Reviews 2026)

This section reviews telehealth services relevant to ketamine treatment and mental health support. The listed services are based on Trustpilot data checked in October 2026. Star ratings can change as they reflect varying customer experiences, with unhappy customers often leaving more reviews.

🥇 1. Direct Meds

Direct Meds has been rated 4.6. This service is known for providing GLP-1 telehealth solutions and compounded medications like semaglutide. However, it has limited insurance acceptance, which may affect some patients seeking treatment for conditions like addiction.

🥈 2. Hims & Hers Health

Hims & Hers Health holds a Trustpilot score of 3.0. It provides a range of online healthcare services, including prescription medications. However, some reviewers have reported customer service issues, which may impact user experience.

🥉 3. LifeStance Health

LifeStance Health has been rated 4.0. This service specializes in mental health services, including therapy and psychiatry via telehealth. However, patients have noted inconsistent service quality and issues with appointment availability.

4️⃣ Talkiatry

Talkiatry has a Trustpilot score of 2.4. It focuses on online psychiatry services and medication management. However, it has been criticized for limited insurance coverage and varying quality of clinicians, which can affect treatment consistency.

🆓 Free Resources for Treatment

The U.S. Department of Labor offers resources for understanding the Mental Health Parity and Addiction Equity Act (MHPAEA). Patients can also access the SAMHSA helpline for information and treatment referrals.

🔎 Considerations When Choosing a Service

  • 🏥 Type of telehealth services offered.
  • 💰 Cost and payment structures.
  • 📞 Availability of consultations and appointment scheduling.
  • 📝 Insurance acceptance and coverage options.
  • 🌟 Overall user satisfaction and reviews.

❓ Frequently Asked Questions

❓ What types of medications can be prescribed via telehealth?

Telehealth can accommodate prescriptions for Schedule II-V controlled substances, including buprenorphine, through video consultations with DEA-registered practitioners.

🔍 Are there specific eligibility requirements for telehealth prescriptions?

Yes, eligibility requires the prescribing practitioner to be registered with the DEA and to conduct a video consultation to assess the patient's medical needs.

⏳ How long does it take to get a telehealth prescription?

Processing times vary by provider; some may offer same-day consultations, while others could take several days to schedule an appointment.

🏛️ What is the Mental Health Parity and Addiction Equity Act?

This act aims to ensure equal treatment of mental health and substance use disorder benefits compared to medical and surgical benefits, reinforcing access to necessary care.

📅 When do the new regulations regarding telehealth prescriptions end?

The current telemedicine flexibilities for prescribing controlled substances are effective through December 31, 2026.

📞 Where can I find free support for substance use disorders?

Individuals can contact the SAMHSA helpline at 1-800-662-HELP (4357) for information and referrals related to mental health and substance use disorders.

⚖️ Recent Cases Related to Drug Laws

Recent court rulings have focused on issues surrounding the regulation of controlled substances and telehealth practices. These cases connect to the ongoing discussions about access to medications like ketamine and the implications of telehealth services.

For more recent rulings, browse more rulings on the news page.

End of October 2026 Update






What is Ketamine?

Ketamine is a popular drug used in human and veterinary medicine. The drug is a hydrochloride salt typically sold as Ketalar, Ketanest and Ketaset. In a pharmacological sense, ketamine is classified as a receptor antagonist. At potent doses, ketamine binds opioid receptors type 2 in neuroblastoma cells. Moreover, the drug interacts with muscarinic receptors and voltage-gated calcium channels. Similar to other drugs of this classification, such as phencyclidine and tiletamine, ketamine induces a state known as “dissociative anesthesia”—the side effect sparks recreational use. 

Ketamine yields a number of side effects in humans, including intense hallucinations, anesthesia, brochodilation and elevated blood pressure. Ketamine is primarily used—in conjunction with a sedative-- for the maintenance of general anesthesia. Other uses of ketamine include analgesia, treatment of bronchospasm and sedation in intensive care. Furthermore, the drug has proven to be effective for the treatment of depression, particularly for patients who exhibit bipolar disorder or who have not responded to other anti-depressants. For individuals who have severe depression disorder, ketamine will produce rapid anti-depressant effects—ketamine triggers effects within 2 hours. 

Ketamine


Ketamine: Recreational Use

Illegal sale of ketamine comes from legitimate supplies or from theft. When used recreationally, Ketamine will produce severe psychological effects that are similar to PCP or DXM. Unlike these drugs, however, ketamine is very short acting—the hallucinatory effects last roughly one hour when injected or insufflated. Similar to other dissociative anesthetics, the hallucinations sparked by ketamine use are fundamentally different from those caused by phenethylamines and tryptamines.  With a low dose, ketamine-induced hallucinations will be only noticed when the user is in a dark room or has his/her eyes closed. At a medium to high dose, the effects are more conspicuous and intense. 

When used recreationally, ketamine will produce a dissociative state, characterized by an overwhelming feeling of detachment from one’s physical being and the external world. At a high dose, a user will experience what is referred to as the “K-hole”, a state of complete dissociation that closely mimics the phenomenology of schizophrenia. A user who experiences the “K-hole” will report extreme hallucinations, perceptions of free-falling, fast movements, the feeling of flight, feeling connected to the universe and thoughts with adjacent abusers. 

A recreational user of ketamine will feel as though their thoughts and perceptions are located so deep within that the real world seems distant or fake. The majority of users may not lucidly remembers such thoughts after regaining consciousness; users report that their experiences with ketamine mimic intense dreaming. 


Short term side effects of recreational Ketamine use include:


• Increased heart rate

• Slurred speech

• Out-of-body experiences

• Sedation

• Euphoria

• Double-vision

• Hypersalivation

• Hypertension and tachycardia


Long-Term Effects Associated with Ketamine Use:

Incessant use of Ketamine may lead to various cognitive impairments including memory loss. The first large-scale evaluation of ketamine users found that heavy abuse lead to impaired memory by several measures, including short-term, visual and verbal memory impairments. Occasional use (1-2 times per month) does not spark such side effects. 


Legal Status:

Ketamine may be only used legally by health professionals or for university research purposes. Ketamine is classified by the United States Government as a Schedule III substance. According to the United States Department of Justice and the Drug Enforcement Administration Schedule III substances have a potential for abuse less than substances listed in the previous two schedules. Schedule III substances may lead to moderate or low physical dependence or a high psychological dependence.